Cardiology

VESALIUS-CV tests evolocumab in diabetic patients without established atherosclerosis, while new trials probe plaque biology and lipid pathways beyond LDL.

A 2026 meta-analysis examines SGLT2 inhibitor use in diabetic heart transplant recipients, a population where evidence has been thin and stakes are high.

A new analysis highlights the complex interplay of cardio-kidney-metabolic (CKM) risk factors in patients with atrial fibrillation, underscoring the need for integrated care models. The study points to significant policy and reimbursement challenges in esta...

Patients with atrial fibrillation often present with a complex interplay of cardio-kidney-metabolic conditions, but large registry data can oversimplify these interactions. Clinicians should interpret such observational findings cautiously, especially when ...

Delayed aortic dissection following TAVI remains a rare, but devastating, complication. The question is whether balloon-expandable valves present a unique biomechanical risk compared to self-expanding alternatives.

Patients undergoing transcarotid transcatheter aortic valve replacement (TCAR TAVR) are at risk of stroke. Monitoring somatosensory-evoked potentials (SSEPs) could provide an early warning sign of cerebral hypoperfusion, allowing for immediate intervention ...